BeOne Medicines AG (BEIGF)
Discovers and develops cancer drugs for blood and solid tumors globally.
$23.75+0.08%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+37.6%
The outlook
BEIGF trades at $23.75, sitting well above both its 50- and 200-day moving averages and positioned near the upper end of its 52-week range. The stock carries a trailing P/E of 69.9, reflecting a premium valuation. Analyst coverage appears limited, so detailed target and consensus data isn't available.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range83% of the way from its 52-week low to high
Market cap
$32.03B
52-wk high
$25.29
52-wk low
$15.95
50-day avg
$22.11
200-day avg
$23.33
Trailing P/E
69.9